Clinical Trial Update: Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating rifampin to reduce foot amputations in diabetics with osteomyelitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Osteomyelitis

Drugs mentioned

• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Osteomyelitis, Diabetes | Phase 4 | Status: COMPLETED